BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 22680919)

  • 1. Significance of genome-wide analysis of copy number alterations and UPD in myelodysplastic syndromes using combined CGH - SNP arrays.
    Ahmad A; Iqbal MA
    Curr Med Chem; 2012; 19(22):3739-47. PubMed ID: 22680919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of previously cryptic copy number alterations and loss of heterozygosity in pediatric acute myeloid leukemia and myelodysplastic syndrome determined using combined array comparative genomic hybridization plus single-nucleotide polymorphism microarray analyses.
    Koh KN; Lee JO; Seo EJ; Lee SW; Suh JK; Im HJ; Seo JJ
    J Korean Med Sci; 2014 Jul; 29(7):926-33. PubMed ID: 25045224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.
    da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F
    J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML.
    Gondek LP; Tiu R; O'Keefe CL; Sekeres MA; Theil KS; Maciejewski JP
    Blood; 2008 Feb; 111(3):1534-42. PubMed ID: 17954704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of single-nucleotide polymorphism array-based whole-genome analysis and uniparental disomy in myelodysplastic syndrome.
    Ou Y; Yang Y; Yu H; Zhang X; Liu M; Wu Y
    Int J Lab Hematol; 2021 Oct; 43(5):1062-1069. PubMed ID: 33650312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes.
    Qin Y; Zhang H; Feng L; Wei H; Wu Y; Jiang C; Xu Z; Zhu H; Liu T
    Ann Med; 2022 Dec; 54(1):2627-2636. PubMed ID: 36148999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies.
    Ronaghy A; Yang RK; Khoury JD; Kanagal-Shamanna R
    Curr Hematol Malig Rep; 2020 Jun; 15(3):194-202. PubMed ID: 32382988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes.
    Gondek LP; Haddad AS; O'Keefe CL; Tiu R; Wlodarski MW; Sekeres MA; Theil KS; Maciejewski JP
    Exp Hematol; 2007 Nov; 35(11):1728-38. PubMed ID: 17920760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of copy number alterations in acute myeloid leukemia and myelodysplastic syndromes.
    Jacoby MA; Walter MJ
    Expert Rev Mol Diagn; 2012 Apr; 12(3):253-64. PubMed ID: 22468816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.
    Tiu RV; Gondek LP; O'Keefe CL; Elson P; Huh J; Mohamedali A; Kulasekararaj A; Advani AS; Paquette R; List AF; Sekeres MA; McDevitt MA; Mufti GJ; Maciejewski JP
    Blood; 2011 Apr; 117(17):4552-60. PubMed ID: 21285439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes.
    Mohamedali A; Gäken J; Twine NA; Ingram W; Westwood N; Lea NC; Hayden J; Donaldson N; Aul C; Gattermann N; Giagounidis A; Germing U; List AF; Mufti GJ
    Blood; 2007 Nov; 110(9):3365-73. PubMed ID: 17634407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress of Clinical Application of SNP-A to MDS--Review].
    Chi K; Jing XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1244-1247. PubMed ID: 30111439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies.
    Dunbar AJ; Gondek LP; O'Keefe CL; Makishima H; Rataul MS; Szpurka H; Sekeres MA; Wang XF; McDevitt MA; Maciejewski JP
    Cancer Res; 2008 Dec; 68(24):10349-57. PubMed ID: 19074904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Array-Based Comparative Genomic Hybridization (aCGH).
    Zhang C; Cerveira E; Romanovitch M; Zhu Q
    Methods Mol Biol; 2017; 1541():167-179. PubMed ID: 27910023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics.
    Heinrichs S; Kulkarni RV; Bueso-Ramos CE; Levine RL; Loh ML; Li C; Neuberg D; Kornblau SM; Issa JP; Gilliland DG; Garcia-Manero G; Kantarjian HM; Estey EH; Look AT
    Leukemia; 2009 Sep; 23(9):1605-13. PubMed ID: 19387468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays.
    Wang L; Fidler C; Nadig N; Giagounidis A; Della Porta MG; Malcovati L; Killick S; Gattermann N; Aul C; Boultwood J; Wainscoat JS
    Haematologica; 2008 Jul; 93(7):994-1000. PubMed ID: 18508791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.
    Huh J; Tiu RV; Gondek LP; O'Keefe CL; Jasek M; Makishima H; Jankowska AM; Jiang Y; Verma A; Theil KS; McDevitt MA; Maciejewski JP
    Genes Chromosomes Cancer; 2010 Apr; 49(4):390-9. PubMed ID: 20095039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.